Effects of recombinant human LH and hCG on serum and urine LH and androgens in men

Clinical Endocrinology

Volumn 71, Issue 3, 2009, Pages 417-428

  Handelsman, David J ^a   Goebel, Catrin ^b   Idan, Amanda ^a   Jimenez, Mark ^a   Trout, Graham ^b   Kazlauskas, Rymantas ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL MEASUREMENT INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; NANDROLONE DECANOATE; TESTOSTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GONADOTROPIN BLOOD LEVEL; HORMONE URINE LEVEL; HUMAN; HUMAN EXPERIMENT; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; ANDROGENS; CHORIONIC GONADOTROPIN; DOPING IN SPORTS; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TESTOSTERONE; YOUNG ADULT;

EID: 68949221165     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03516.x     Document Type: Article

References (59)

1. Choong, K., Lakshman, K.M. Bhasin, S. (2008) The physiological and pharmacological basis for the ergogenic effects of androgens in elite sports. Asian Journal of Andrology, 10, 351 363.
2. Catlin, D.H., Ahrens, B.D. Kucherova, Y. (2002) Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Communications in Mass Spectrometry, 16, 1273 1275.
3. Death, A.K., McGrath, K.C., Kazlauskas, R. et al. (2004) Tetrahydrogestrinone is a potent androgen and progestin. Journal of Clinical Endocrinology and Metabolism, 89, 2498 2500.
4. Catlin, D.H., Sekera, M.H., Ahrens, B.D. et al. (2004) Tetrahydrogestrinone: discovery, synthesis, and detection. Rapid Communications in Mass Spectrometry, 18, 1245 1249.
5. Diel, P., Friedel, A., Geyer, H. et al. (2007) Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicology Letters, 169, 64 71.
6. Handelsman, D.J. (2004) Designer androgens in sport: when too much is never enough. Science's STKE 2004 : pe41.
7. Handelsman, D.J. (2006) Clinical review: the rationale for banning human chorionic gonadotrophin and estrogen blockers in sport. Journal of Clinical Endocrinology and Metabolism, 91, 1646 1653.
8. Matsumoto, A.M., Paulsen, C.A. Bremner, W.J. (1984) Stimulation of sperm production by human luteinizing hormone in gonadotrophin-suppressed normal men. Journal of Clinical Endocrinology and Metabolism, 59, 882 887.
9. Minto, C., Howe, C., Wishart, S. et al. (1997) Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and volume. Journal of Pharmacology and Experimental Therapeutics, 281, 93 102.
10. Liu, P.Y., Wishart, S.M. Handelsman, D.J. (2002) A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotrophin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency. Journal of Clinical Endocrinology and Metabolism, 87, 3125 3135.
11. Sikaris, K., McLachlan, R.I., Kazlauskas, R. et al. (2005) Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. Journal of Clinical Endocrinology and Metabolism, 90, 5928 5936.
12. Geyer, H., Schanzer, W., Mareck-Englke, U. et al. (1996) Factors influencing the steroid profile. In : M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke eds. Recent Advances in Doping Analysis. Cologne : Sport und Buch Strauss, 95 113.
13. Greenberg, G.N. Levine, R.J. (1989) Urinary creatinine excretion is not stable: a new method for assessing urinary toxic substance concentrations. Journal of Occupational Medicine, 31, 832 838.
14. Miller, R.C., Brindle, E., Holman, D.J. et al. (2004) Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clinical Chemistry, 50, 924 932.
15. Verbraecken, J., Van de Heyning, P., De Backer, W. et al. (2006) Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism, 55, 515 524.
16. Delbeke, F.T., Van Eenoo, P. De Backer, P. (1998) Detection of human chorionic gonadotrophin misuse in sports. International Journal of Sports Medicine, 19, 287 290.
17. Robinson, N., Saudan, C., Sottas, P.E. et al. (2007) Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone. Journal of Pharmaceutical and Biomedical Analysis, 43, 270 276.
18. O'Connor, J.F., Kovalevskaya, G., Birken, S. et al. (1998) The expression of the urinary forms of human luteinizing hormone beta fragment in various populations as assessed by a specific immunoradiometric assay. Human Reproduction, 13, 826 835.
19. Thevis, M. Schanzer, W. (2007) Mass spectrometric identification of peptide hormones in doping-control analysis. Analyst, 132, 287 291.
20. Liu, C.L. Bowers, L.D. (1996) Immunoaffinity trapping of urinary human chorionic gonadotrophin and its high-performance liquid chromatographic-mass spectrometric confirmation. Journal of Chromatography. B, Biomedical Applications, 687, 213 220.
21. Gam, L.H., Tham, S.Y. Latiff, A. (2003) Immunoaffinity extraction and tandem mass spectrometric analysis of human chorionic gonadotrophin in doping analysis. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 792, 187 196.
22. Manna, P.R., Joshi, L., Reinhold, V.N. et al. (2002) Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Human Molecular Genetics, 11, 301 315.
23. Hakola, K., Haavisto, A.M., Pierroz, D.D. et al. (1998) Recombinant forms of rat and human luteinizing hormone and follicle-stimulating hormone; comparison of functions in vitro and in vivo. Journal of Endocrinology, 158, 441 448.
24. le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. et al. (1998) Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertility and Sterility, 69, 189 194.
25. le Cotonnec, J.Y., Loumaye, E., Porchet, H.C. et al. (1998) Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertility and Sterility, 69, 201 209.
26. le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. et al. (1998) Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. Fertility and Sterility, 69, 195 200.
27. Rosa, C., Amr, S., Birken, S. et al. (1984) Effect of desialylation of human chorionic gonadotrophin on its metabolic clearance rate in humans. Journal of Clinical Endocrinology and Metabolism, 59, 1215 1219.
28. Bouloux, P.M., Handelsman, D.J., Jockenhovel, F. et al. (2001) First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Human Reproduction, 16, 1592 1597.
29. Joshi, L., Murata, Y., Wondisford, F.E. et al. (1995) Recombinant thyrotropin containing a β-subunit chimera with the human chorionic gonadotrophin-β carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance. Endocrinology, 136, 3839 3848.
30. Fares, F., Ganem, S., Hajouj, T. et al. (2007) Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotrophin β-subunit to the coding sequence of human erythropoietin. Endocrinology, 148, 5081 5087.
31. Liu, P.Y., Gebski, V.J., Turner, L. et al. (2002) Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin deficient infertile men. Human Reproduction, 17, 625 633.
32. Mochtar, M.H.V., Ziech, M. van Wely, M. (2007) Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews : CD005070.
33. Garcia-Velasco, J.A., Coelingh Bennink, H.J., Epifanio, R. et al. (2007) High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. Reproductive Biomedicine Online, 15, 280 287.
34. Durnerin, C.I., Erb, K., Fleming, R. et al. (2008) Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation. Human Reproduction, 23, 421 426.
35. Young, J., Couzinet, B., Chanson, P. et al. (2000) Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. Journal of Clinical Endocrinology and Metabolism, 85, 3239 3244.
36. Veldhuis, J.D. Iranmanesh, A. (2004) Pulsatile intravenous infusion of recombinant human luteinizing hormone under acute gonadotrophin-releasing hormone receptor blockade reconstitutes testosterone secretion in young men. Journal of Clinical Endocrinology and Metabolism, 89, 4474 4479.
37. Veldhuis, J.D., Veldhuis, N.J., Keenan, D.M. et al. (2005) Age diminishes the testicular steroidogenic response to repeated intravenous pulses of recombinant human LH during acute GnRH-receptor blockade in healthy men. American Journal of Physiology. Endocrinology and Metabolism, 288, E775 E781.
38. Liu, P.Y., Takahashi, P.Y., Roebuck, P.D. et al. (2005) Aging in healthy men impairs recombinant human luteinizing hormone (LH)-stimulated testosterone secretion monitored under a two-day intravenous pulsatile LH clamp. Journal of Clinical Endocrinology and Metabolism, 90, 5544 5550.
39. Takahashi, P.Y., Votruba, P., Abu-Rub, M. et al. (2007) Age attenuates testosterone secretion driven by amplitude-varying pulses of recombinant human luteinizing hormone during acute gonadotrope inhibition in healthy men. Journal of Clinical Endocrinology and Metabolism, 92, 3626 3632.
40. Mulligan, T., Iranmanesh, A. Veldhuis, J.D. (2001) Pulsatile iv infusion of recombinant human LH in leuprolide-suppressed men unmasks impoverished Leydig-cell secretory responsiveness to midphysiological LH drive in the aging male. Journal of Clinical Endocrinology and Metabolism, 86, 5547 5553.
41. Trinchard-Lugan, I., Khan, A., Porchet, H.C. et al. (2002) Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reproductive Biomedicine Online, 4, 106 115.
42. van der Merwe, R., Lugan, I., Lecuelle, H. et al. (2004) The bioequivalence of liquid and freeze-dried formulations of recombinant human chorionic gonadotrophin. Current Medical Research Opinions, 20, 397 402.
43. Padron, R.S., Wischusen, J., Hudson, B. et al. (1980) Prolonged biphasic response of plasma testosterone to single intramuscular injections of human chorionic gonadotrophin. Journal of Clinical Endocrinology and Metabolism, 50, 1100 1104.
44. Saal, W., Glowania, H.J., Hengst, W. et al. (1991) Pharmacodynamics and pharmacokinetics after subcutaneous and intramuscular injection of human chorionic gonadotrophin. Fertility and Sterility, 56, 225 229.
45. Kicman, A.T., Brooks, R.V., Collyer, S.C. et al. (1990) Criteria to indicate testosterone administration. British Journal of Sports Medicine, 24, 253 264.
46. Perry, P.J., MacIndoe, J.H., Yates, W.R. et al. (1997) Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone. Clinical Chemistry, 43, 731 735.
47. Palonek, E., Gottlieb, C., Garle, M. et al. (1995) Serum and urinary markers of exogenous testosterone administration. Journal of Steroid Biochemistry and Molecular Biology, 55, 121 127.
48. Carlstrom, K., Palonek, E., Garle, M. et al. (1992) Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17 α-hydroxyprogesterone. Clinical Chemistry, 38, 1779 1784.
49. Kicman, A.T., Brooks, R.V. Cowan, D.A. (1991) Human chorionic gonadotrophin and sport. British Journal of Sports Medicine, 25, 73 80.
50. Cowan, D.A., Kicman, A.T., Walker, C.J. et al. (1991) Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes. Journal of Endocrinology, 131, 147 154.
51. Laidler, P., Cowan, D.A., Hider, R.C. et al. (1994) New decision limits and quality-control material for detecting human chorionic gonadotrophin misuse in sports. Clinical Chemistry, 40, 1306 1311.
52. Chen, H.C., Hodgen, G.D., Matsuura, S. et al. (1976) Evidence for a gonadotrophin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotrophin. Proceedings of the National Academy of Sciences of the United States of America, 73, 2885 2889.
53. Huhtaniemi, I.T., Korenbrot, C.C. Jaffe, R.B. (1978) Content of chorionic gonadotrophin in human fetal tissues. Journal of Clinical Endocrinology and Metabolism, 46, 994 997.
54. Braunstein, G.D., Kamdar, V., Rasor, J. et al. (1979) Widespread distribution of a chorionic gonadotrophin-like substance in normal human tissues. Journal of Clinical Endocrinology and Metabolism, 49, 917 925.
55. Armstrong, E.G., Ehrlich, P.H., Birken, S. et al. (1984) Use of a highly sensitive and specific immunoradiometric assay for detection of human chorionic gonadotrophin in urine of normal, nonpregnant, and pregnant individuals. Journal of Clinical Endocrinology and Metabolism, 59, 867 874.
56. Stenman, U.H., Unkila-Kallio, L., Korhonen, J. et al. (1997) Immunoprocedures for detecting human chorionic gonadotrophin: clinical aspects and doping control. Clinical Chemistry, 43, 1293 1298.
57. Olivares, A., Cardenas, M., Timossi, C. et al. (2000) Reactivity of different LH and FSH standards and preparations in the world health organization matched reagents for enzyme-linked immunoassays of gonadotrophins. Human Reproduction, 15, 2285 2291.
58. Saugy, M., Robinson, N., Saudan, C. et al. (2006) Human growth hormone doping in sport. British Journal of Sports Medicine, 40 (Suppl. 1 i35 i39.
59. Baoutina, A., Alexander, I.E., Rasko, J.E. et al. (2008) Developing strategies for detection of gene doping. Journal of Gene Medicine, 10, 3 20.